StockMarketWire.com - Allergy and infectious disease focused Omega Diagnostics said it had signed a global distribution agreement with Immunodiagnostic Systems for its allergy assays.

The partnership was for the long-term supply of the company's Allersys assay range.

'Whilst we expect modest sales growth in the short term as we work together to further expand our menu, we are excited that with our development capability and IDS instrument and commercial expertise we can make a significant difference within the allergy testing market,' chief executive Colin King said.

'We believe our product offers a more flexible and efficient work-flow solution for small to mid-size laboratories.'


At 9:15am: [LON:ODX] Omega Diagnostics Group PLC share price was +1.35p at 10.1p



Story provided by StockMarketWire.com